Adenosine Triphosphate
In clinical developmentAlso known as ATP, ADT - Adenosine triphosphate, ATP - Adenosine triphosphate, Adenosine 5'-triphosphate+1 more
ATP, ADT - Adenosine triphosphate, ATP - Adenosine triphosphate, Adenosine 5'-triphosphate, Adenosine-5'-triphosphate.
Recent clinical, regulatory, research and industry developments relating to this drug.
The Safety, Feasibility, and Repeatability of Inhaled ATP Cough Challenges
Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond.
Mitochondrial pyruvate transport regulates presynaptic metabolism and neurotransmission.
Electro-Metabolic Coupling of Cumulus-Oocyte Complex.
PFOS-elicited metabolic perturbation in liver and fatty acid metabolites in testis of adult mice.
The Immune Regulatory Role of Adenosine in the Tumor Microenvironment.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- International journal of molecular sciences3
- Frontiers in endocrinology2
- Frontiers in immunology2
- Advanced science (Weinheim, Baden-Wurttemberg, Germany)1
- Annual review of cell and developmental biology1
- British journal of pharmacology1
- Acosta N1
- Alsalman MM1
- Ashrafi G1
- Assam Assam JP1
- Aziz M1
- Baldini GM1
- Biagini A1
- Bowo-Ngandji A1
- "Madonna delle Grazie" Hospital ASM1
- Acupuncture and Tuina School1
- Biofluid Biomarker Center1
- Bispebjerg University Hospital1
- Cardiovascular Research Center1
- Center for Immunology and Inflammation1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 6 of the same disease areas as Adenosine Triphosphate in the shared literature.
Studied across 5 of the same disease areas as Adenosine Triphosphate in the shared literature.
Studied across 4 of the same disease areas as Adenosine Triphosphate in the shared literature.
Studied across 4 of the same disease areas as Adenosine Triphosphate in the shared literature.
Studied across 4 of the same disease areas as Adenosine Triphosphate in the shared literature.
Studied across 3 of the same disease areas as Adenosine Triphosphate in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials